(FM) Unidad de Medicina Traslacional
Departamento académico
Juan José
Lasarte Sagastibelza
Catedrático de Universidad
Publications dans lesquelles il/elle collabore avec Juan José Lasarte Sagastibelza (39)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
-
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
Frontiers in Immunology, Vol. 13
-
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
Cancer Letters, Vol. 528, pp. 45-58
2020
-
Id1 and pd-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-l1 expression and tumor infiltrating CD8+ T cells
Cancers, Vol. 12, Núm. 11, pp. 1-22
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2019
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
2018
-
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in b lymphoid neoplasms
Haematologica, Vol. 103, Núm. 6, pp. 1065-1072
2017
-
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Nature Communications, Vol. 8
-
Expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy
Cancer Research, Vol. 77, Núm. 13, pp. 3672-3684
-
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination
Oncotarget, Vol. 8, Núm. 2, pp. 2659-2671
2016
-
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Journal of Medical Virology, Vol. 88, Núm. 5, pp. 843-851
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
-
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation
Journal of Immunology, Vol. 195, Núm. 7, pp. 3180-3189
2013
-
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88
2012
-
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression
Journal of Immunology, Vol. 189, Núm. 9, pp. 4674-4683
2011
-
Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors
Cancer Research, Vol. 71, Núm. 9, pp. 3214-3224
-
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells
Hepatology, Vol. 54, Núm. 1, pp. 28-37
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31